Oral sildenafil for PPHN in neonates: Selection of patients remains a dilemma?

Journal of the College of Physicians and Surgeons Pakistan

Volumn 18, Issue 2, 2008, Pages 132-133

  Garg, Pankaj ^a  

^a Central Hospital and Research Centre ^*  (India)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL LUNG SURFACTANT; BICARBONATE; HYPERTENSIVE FACTOR; OXYGEN; SILDENAFIL;

ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; CHILDBIRTH; DRUG TREATMENT FAILURE; ECHOCARDIOGRAPHY; FEMALE; HUMAN; HYPOXEMIA; LUNG HYPOPLASIA; LUNG VOLUME; MALE; NEWBORN; NEWBORN DEATH; OFF LABEL DRUG USE; OXYGEN TENSION; PATIENT SELECTION; PERSISTENT PULMONARY HYPERTENSION; PNEUMOTHORAX; THORAX DRAINAGE; THORAX RADIOGRAPHY;

ADMINISTRATION, ORAL; FATAL OUTCOME; FEMALE; HUMANS; INFANT, NEWBORN; MALE; PERSISTENT FETAL CIRCULATION SYNDROME; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PURINES; SULFONES;

EID: 42149136294     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Cook LN, Stewart DL. Inhaled nitric oxide in the treatment of persistent pulmonary hypertension/hypoxic respiratory failure in neonates: an update. J Ky Med Assoc 2005; 103: 138-47.
2. Konduri GG. New approaches for persistent pulmonary hypertension of newborn. Clin Perinatol 2004; 31: 591-611.
3. Dakshinamurti S. Pathophysiologic mechanisms of persistent pulmonary hypertension of the newborn. Pediatr Pulmonol 2005; 39: 492-503.
4. Oishi P, Fineman JR. Pharmacologic therapy for persistent pulmonary hypertension of the newborn: as "poly" as the disease itself. Pediatr Crit Care Med 2004; 5:94-6.
5. Baquero H, Soliz A, Neira F, Venegas ME, Sola A. Oral sildenafil with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study. Pediatrics 2006; 117: 1077-83.
6. Simiyu DE, Okello C, Nyakundi EG, Tawakal AH. Sildenafil in management of persistent hypertension of the newborn: report of two cases. East Afr Med J 2006; 83: 337-40.
7. Juliana AE, Abbad FC. Severe persistent pulmonary hypertension of the newborn in a setting where limited resources exclude the use of inhaled nitric oxide: successful treatment with sildenafil. Eur J Pediatr 2005; 164: 626-9.
8. Chaudhari M, Vogel M, Wright C, Smith J, Haworth SG. Sildenafil in neonatal pulmonary hypertension due to impaired alveolarisation and plexiform pulmonary ateriopathy. Arch Dis Child Fetal Neonatal Ed 2005; 90: F527-8.
9. Garcia Martinez E, Ibarra. de la Rosa I, Perez Navero JL, Tejero Matto I, Exposito Montes JF, Suarez de Lezo ycruz Conde J. Sildenafil in the treatment of pulmonary hypertension. Ann Pediatr (Barc) 2003; 59:110-3.
10. Harris K. Extralobar sequestration with congenital diaphragmatic hernia: a complicated case study. Neonatal Netw 2004; 23: 7-24.
11. Binns-Loveman KM, Kaplowitz MR, Fike CD. Sildenafil and an early stage of chronic hypoxia-induced pulmonary hypertension in newborn piglets. Pediatr Pulmonol 2005; 40: 72-80.
12. Patole S, Travadi J. Sildenafil for "blue babies". Ethics, conscience, and science have to be balanced against limited resources. BMJ 2002; 325: 1174.